TDB Drives Local Innovation in Complex Pharma Excipients

Highlights:- 

• TDB funds Nitika to boost domestic production of complex pharma excipients
• Project selected under the PLI scheme for MSME pharmaceuticals
• Nitika serves 90-plus countries with DSIR-approved R&D expertise

Indian Technology Development Board (TDB), which operates under the Department of Science and Technology (DST), has provided financial support to the excipient producer of pharmaceuticals, Nitika Pharmaceutical Specialties Pvt. Ltd., based at Nagpur. The move is intended to boost India's base of excipient manufacturing and lower import dependence.

Nitika Pharmaceutical Specialties is setting up a state-of-the-art manufacturing plant at Nagpur for the manufacture of 14 advanced excipients for high-end pharmaceutical use. Such products will be produced on the basis of the Quality by Design (QbD) approach with accuracy in parameters such as surface area, particle size, and stability to international standards. The project is aligned with the Production Linked Incentive (PLI) policy of the Government of India for pharmaceuticals, under which Nitika has been chosen as a beneficiary under Group C – MSME (Pharmaceuticals).

Also Read: India's Growth to 4th Spot Signals MedTech Boost: AiMeD

TDB facilitation aligns with the overall national agenda of increasing indigenous production, lowering dependence on imports, and increasing India's export potential in high-value pharmaceutical intermediates. TDB Secretary Rajesh Kumar Pathak underlined that India has to emerge as a world-class manufacturer, not only as a pharmacy of the world but as a manufacturer of world-class excipients as well.

Founded in 1991, Nitika Pharmaceutical Specialties has grown to become an established worldwide supplier of specialty excipients and quality chemicals. It has an in-house R&D facility that is DSIR-recognized and sells its products to more than 90 countries. India is at the center of the pharmaceutical world of the globe, yet the country imports many complicated excipients from nations such as France, China, and the United States. This collaboration between Nitika and TDB attempts to bridge this gap and boost the autonomy of India in the pharmaceutical industry.